↑ Rising
Business
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug
Roche lung cancer drug extends survival by nearly six months in late-stage trial
Kras Mutation
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Kras Mutation
This hub groups 2 separate news trends connected to Kras Mutation, spanning August 9, 2026 through October 26, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 16 article observations and 16 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.